NIH-funded research R21 grant

Exploring bat stem cells to understand their unique biology

Official title: Bat pluripotent stem cells as a novel experimental system

Funded at Icahn School of Medicine at Mount Sinai · NIH-10906740 · Data updated 2026-11-12

This study is looking at special cells from bats to learn more about how they stay healthy and fight off diseases, which could help us understand their unique abilities better.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 14, 2023
Project endJuly 31, 2025
Funding year2024
Award (this year)$211,250
NIH project number5R21AI169516-02
Project IDNIH-10906740 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals interested in the biological mechanisms of immunity and metabolism, particularly in relation to zoonotic diseases.

Less likely to help

Patients with conditions unrelated to immune response or metabolic disorders may not receive direct benefits from this research.

What this research studies

This research investigates induced pluripotent stem cells (iPSCs) derived from bats, aiming to understand their unique biological characteristics. The team has already created the first bat iPSCs and found that they exhibit distinct metabolic and immune responses. By using CRISPR technology, the researchers plan to modify specific genes in these cells to further explore their immune responses and metabolic pathways. This work could provide insights into bat physiology and their remarkable resilience to diseases.

Why it matters

Potential benefit: If successful, this research could lead to breakthroughs in understanding immune responses and metabolic processes that may benefit human health.

How similar studies have gone: While research on bat biology is limited, the use of iPSCs and CRISPR technology has shown promise in other animal models, suggesting potential for success in this novel approach.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Zwaka, Thomas P. — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Zwaka, Thomas P.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.